299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02661438 (ClinicalTrials.gov)	January 12, 2016	30/12/2015	Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo	Multicenter Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation in Subjects With Non-Cystic Fibrosis Bronchiectasis (NCFB) or Chronic Obstructive Pulmonary Disease (COPD) Using Matching Placebo	Bronchiectasis;Pulmonary Disease, Chronic Obstructive	Drug: Placebo to Ciprofloxacin DPI (BAYQ3939)	Bayer	Novartis	Completed	40 Years	N/A	All	46	N/A	United States
2	NCT01764841 (ClinicalTrials.gov)	May 2, 2013	8/1/2013	Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)	Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.	Bronchiectasis	Drug: Ciprofloxacin DPI (BAYQ3939);Drug: Placebo	Bayer	Novartis	Completed	18 Years	N/A	All	416	Phase 3	United States;Argentina;Australia;Denmark;France;Germany;Israel;Italy;Japan;Latvia;New Zealand;Slovakia;Spain;United Kingdom